Compare DUOL & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOL | NOVT |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.0B |
| IPO Year | 2021 | 1999 |
| Metric | DUOL | NOVT |
|---|---|---|
| Price | $142.86 | $144.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $176.69 | $144.00 |
| AVG Volume (30 Days) | ★ 1.3M | 396.3K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 355.85 | N/A |
| EPS | ★ 1.53 | 0.82 |
| Revenue | ★ $1,037,589,000.00 | $521,290,000.00 |
| Revenue This Year | $18.93 | $8.61 |
| Revenue Next Year | $14.02 | $6.57 |
| P/E Ratio | ★ $92.08 | $175.56 |
| Revenue Growth | ★ 38.71 | 35.49 |
| 52 Week Low | $87.89 | $98.27 |
| 52 Week High | $353.00 | $176.38 |
| Indicator | DUOL | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 41.31 |
| Support Level | $142.10 | $132.80 |
| Resistance Level | $151.00 | $149.42 |
| Average True Range (ATR) | 7.18 | 5.99 |
| MACD | 0.18 | -2.28 |
| Stochastic Oscillator | 61.83 | 14.71 |
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue: time-based subscriptions, in-app advertising placement by third parties, the Duolingo English Test, and In-App purchases. Geographically, the company generates revenue from its customers in the United States and other markets.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.